4160 Stock Overview
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Genetics Generation Advancement Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$43.20 |
| 52 Week High | NT$52.40 |
| 52 Week Low | NT$28.44 |
| Beta | 0.50 |
| 1 Month Change | 5.88% |
| 3 Month Change | 1.41% |
| 1 Year Change | 48.16% |
| 3 Year Change | 81.78% |
| 5 Year Change | 59.10% |
| Change since IPO | -2.18% |
Recent News & Updates
Shareholder Returns
| 4160 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | -1.5% | -0.5% | 1.8% |
| 1Y | 48.2% | -22.5% | 28.5% |
Return vs Industry: 4160 exceeded the TW Biotechs industry which returned -22.5% over the past year.
Return vs Market: 4160 exceeded the TW Market which returned 28.5% over the past year.
Price Volatility
| 4160 volatility | |
|---|---|
| 4160 Average Weekly Movement | 3.6% |
| Biotechs Industry Average Movement | 4.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 8.2% |
| 10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 4160 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4160's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | n/a | www.gga.asia |
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan, Asia, Europe, and the Americas. The company offers pre-pregnancy test, pregnancy test, newborn testing, adult health management genetic testing, adult cancer and pharmacogenetic testing, and cooperative institutes. It also provides life sciences, materials sciences, laboratory informatics, enterprise quality management system, MES, electronic delivery services.
Genetics Generation Advancement Corp. Fundamentals Summary
| 4160 fundamental statistics | |
|---|---|
| Market cap | NT$1.10b |
| Earnings (TTM) | NT$28.57m |
| Revenue (TTM) | NT$592.50m |
38.4x
P/E Ratio1.9x
P/S RatioIs 4160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4160 income statement (TTM) | |
|---|---|
| Revenue | NT$592.50m |
| Cost of Revenue | NT$355.67m |
| Gross Profit | NT$236.83m |
| Other Expenses | NT$208.27m |
| Earnings | NT$28.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12 |
| Gross Margin | 39.97% |
| Net Profit Margin | 4.82% |
| Debt/Equity Ratio | 7.0% |
How did 4160 perform over the long term?
See historical performance and comparison